Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1992 May;106(1):133–138. doi: 10.1111/j.1476-5381.1992.tb14305.x

The pharmacological modulation of thrombin-induced cerebral thromboembolism in the rabbit.

G R May 1, W Paul 1, P Crook 1, K D Butler 1, C P Page 1
PMCID: PMC1907433  PMID: 1504722

Abstract

1. Intracarotid (i.c.) administration of thrombin induced a marked accumulation of 111indium-labelled platelets and 125I-labelled fibrinogen within the cranial vasculature of anaesthetized rabbits. 2. Thrombin (100 iu kg-1, i.c.) - induced platelet accumulation was completely abolished by pretreatment with desulphatohirudin (CGP 39393; 1 mg kg-1 i.c., 1 min prior to thrombin). Administration of CGP 39393 1 or 20 min after thrombin produced a significant reduction in platelet accumulation. 3. Intravenous (i.v.) administration of the platelet activating factor (PAF) receptor antagonist BN 52021 (10 mg kg-1) 5 min prior to thrombin (100 iu kg-1, i.c.) had no effect on platelet accumulation. 4. An inhibitor of NO biosynthesis, L-NG-nitro arginine methyl ester (L-NAME; 100 mg kg-1, i.c.), had no significant effect on the cranial platelet accumulation response to thrombin (10 iu kg-1, i.c.) when administered 5 min prior to thrombin. 5. Defibrotide (32 or 64 mg kg-1 bolus i.c. followed by 32 or 64 mg kg-1 h-1, i.c., infusion for 45 min) treatment begun 20 min after thrombin (100 iu kg-1, i.c.) did not significantly modify the cranial platelet accumulation response. 6. Cranial platelet accumulation induced by thrombin (100 iu kg-1, i.c.) was significantly reversed by the fibrinolytic drugs urokinase (20 iu kg-1, i.c., infusion for 45 min), anisoylated plasminogen streptokinase activator complex (APSAC) (200 micrograms kg-1, i.v. bolus) or recombinant tissue plasminogen activator (rt-PA; 100 micrograms kg-1, i.c. bolus followed by 20 micrograms kg-1 min-1, i.c., infusion for 45 min) administered 20 min after thrombin.(ABSTRACT TRUNCATED AT 250 WORDS)

Full text

PDF
133

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ANTHONY L. U., GOLDRING S., O'LEARY J. L., SCHWARTZ H. G. Experimental cerebrovascular occlusion in dog. Arch Neurol. 1963 May;8:515–527. doi: 10.1001/archneur.1963.00460050065008. [DOI] [PubMed] [Google Scholar]
  2. Alheid U., Frölich J. C., Förstermann U. Endothelium-derived relaxing factor from cultured human endothelial cells inhibits aggregation of human platelets. Thromb Res. 1987 Sep 1;47(5):561–571. doi: 10.1016/0049-3848(87)90361-6. [DOI] [PubMed] [Google Scholar]
  3. Azuma H., Ishikawa M., Sekizaki S. Endothelium-dependent inhibition of platelet aggregation. Br J Pharmacol. 1986 Jun;88(2):411–415. doi: 10.1111/j.1476-5381.1986.tb10218.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Bederson J. B., Pitts L. H., Tsuji M., Nishimura M. C., Davis R. L., Bartkowski H. Rat middle cerebral artery occlusion: evaluation of the model and development of a neurologic examination. Stroke. 1986 May-Jun;17(3):472–476. doi: 10.1161/01.str.17.3.472. [DOI] [PubMed] [Google Scholar]
  5. Bhardwaj R., Page C. P., May G. R., Moore P. K. Endothelium-derived relaxing factor inhibits platelet aggregation in human whole blood in vitro and in the rat in vivo. Eur J Pharmacol. 1988 Nov 15;157(1):83–91. doi: 10.1016/0014-2999(88)90474-8. [DOI] [PubMed] [Google Scholar]
  6. Coyle A. J., Page C. P., Atkinson L., Sjoerdsma K., Touvay C., Metzger W. J. Modification of allergen-induced airway obstruction and airway hyperresponsiveness in an allergic rabbit model by the selective platelet-activating factor antagonist, BN 52021. J Allergy Clin Immunol. 1989 Dec;84(6 Pt 1):960–967. doi: 10.1016/0091-6749(89)90395-3. [DOI] [PubMed] [Google Scholar]
  7. Furlong B., Henderson A. H., Lewis M. J., Smith J. A. Endothelium-derived relaxing factor inhibits in vitro platelet aggregation. Br J Pharmacol. 1987 Apr;90(4):687–692. doi: 10.1111/j.1476-5381.1987.tb11221.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Hegedüs K., Fekete I., Tury F., Molnár L. Experimental focal cerebral ischaemia in rabbits. J Neurol. 1985;232(4):223–230. doi: 10.1007/BF00313784. [DOI] [PubMed] [Google Scholar]
  9. Hellewell P. G., Williams T. J. Antagonism of Paf-induced oedema formation in rabbit skin: a comparison of different antagonists. Br J Pharmacol. 1989 May;97(1):171–180. doi: 10.1111/j.1476-5381.1989.tb11939.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Heras M., Chesebro J. H., Penny W. J., Bailey K. R., Badimon L., Fuster V. Effects of thrombin inhibition on the development of acute platelet-thrombus deposition during angioplasty in pigs. Heparin versus recombinant hirudin, a specific thrombin inhibitor. Circulation. 1989 Mar;79(3):657–665. doi: 10.1161/01.cir.79.3.657. [DOI] [PubMed] [Google Scholar]
  11. Hogan J. C., Lewis M. J., Henderson A. H. In vivo EDRF activity influences platelet function. Br J Pharmacol. 1988 Aug;94(4):1020–1022. doi: 10.1111/j.1476-5381.1988.tb11616.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Ignarro L. J., Buga G. M., Byrns R. E., Wood K. S., Chaudhuri G. Endothelium-derived relaxing factor and nitric oxide possess identical pharmacologic properties as relaxants of bovine arterial and venous smooth muscle. J Pharmacol Exp Ther. 1988 Jul;246(1):218–226. [PubMed] [Google Scholar]
  13. Kaneko D., Nakamura N., Ogawa T. Cerebral infarction in rats using homologous blood emboli: development of a new experimental model. Stroke. 1985 Jan-Feb;16(1):76–84. doi: 10.1161/01.str.16.1.76. [DOI] [PubMed] [Google Scholar]
  14. Kimani G., Tonnesen M. G., Henson P. M. Stimulation of eosinophil adherence to human vascular endothelial cells in vitro by platelet-activating factor. J Immunol. 1988 May 1;140(9):3161–3166. [PubMed] [Google Scholar]
  15. LEVINE S., KLEIN M. Ischemic infarction and swelling in the rat brain. Arch Pathol. 1960 May;69:544–553. [PubMed] [Google Scholar]
  16. Lamas A. M., Mulroney C. M., Schleimer R. P. Studies on the adhesive interaction between purified human eosinophils and cultured vascular endothelial cells. J Immunol. 1988 Mar 1;140(5):1500–1505. [PubMed] [Google Scholar]
  17. Levine S., Sohn D. Cerebral ischemia in infant and adult gerbils. Relation to incomplete circle of Willis. Arch Pathol. 1969 Mar;87(3):315–317. [PubMed] [Google Scholar]
  18. Lynch J. M., Henson P. M. The intracellular retention of newly synthesized platelet-activating factor. J Immunol. 1986 Oct 15;137(8):2653–2661. [PubMed] [Google Scholar]
  19. Malik A. B. Pulmonary microembolism. Physiol Rev. 1983 Jul;63(3):1114–1207. doi: 10.1152/physrev.1983.63.3.1114. [DOI] [PubMed] [Google Scholar]
  20. Markwardt F., Hauptmann J., Nowak G., Klessen C., Walsmann P. Pharmacological studies on the antithrombotic action of hirudin in experimental animals. Thromb Haemost. 1982 Jun 28;47(3):226–229. [PubMed] [Google Scholar]
  21. May G. R., Crook P., Moore P. K., Page C. P. The role of nitric oxide as an endogenous regulator of platelet and neutrophil activation within the pulmonary circulation of the rabbit. Br J Pharmacol. 1991 Mar;102(3):759–763. doi: 10.1111/j.1476-5381.1991.tb12246.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. May G. R., Herd C. M., Butler K. D., Page C. P. Radioisotopic model for investigating thromboembolism in the rabbit. J Pharmacol Methods. 1990 Aug;24(1):19–35. doi: 10.1016/0160-5402(90)90046-n. [DOI] [PubMed] [Google Scholar]
  23. McIntyre T. M., Zimmerman G. A., Satoh K., Prescott S. M. Cultured endothelial cells synthesize both platelet-activating factor and prostacyclin in response to histamine, bradykinin, and adenosine triphosphate. J Clin Invest. 1985 Jul;76(1):271–280. doi: 10.1172/JCI111957. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Mohr J. P., Caplan L. R., Melski J. W., Goldstein R. J., Duncan G. W., Kistler J. P., Pessin M. S., Bleich H. L. The Harvard Cooperative Stroke Registry: a prospective registry. Neurology. 1978 Aug;28(8):754–762. doi: 10.1212/wnl.28.8.754. [DOI] [PubMed] [Google Scholar]
  25. Moore P. K., al-Swayeh O. A., Chong N. W., Evans R. A., Gibson A. L-NG-nitro arginine (L-NOARG), a novel, L-arginine-reversible inhibitor of endothelium-dependent vasodilatation in vitro. Br J Pharmacol. 1990 Feb;99(2):408–412. doi: 10.1111/j.1476-5381.1990.tb14717.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Nesheim M. E., Mann K. G. Thrombin-catalyzed activation of single chain bovine factor V. J Biol Chem. 1979 Feb 25;254(4):1326–1334. [PubMed] [Google Scholar]
  27. Penar P. L. A model of embolic cerebral ischemia in the rat. Exp Neurol. 1987 May;96(2):393–405. doi: 10.1016/0014-4886(87)90057-4. [DOI] [PubMed] [Google Scholar]
  28. Radomski M. W., Palmer R. M., Moncada S. Endogenous nitric oxide inhibits human platelet adhesion to vascular endothelium. Lancet. 1987 Nov 7;2(8567):1057–1058. doi: 10.1016/s0140-6736(87)91481-4. [DOI] [PubMed] [Google Scholar]
  29. Reimer K. A., Lowe J. E., Rasmussen M. M., Jennings R. B. The wavefront phenomenon of ischemic cell death. 1. Myocardial infarct size vs duration of coronary occlusion in dogs. Circulation. 1977 Nov;56(5):786–794. doi: 10.1161/01.cir.56.5.786. [DOI] [PubMed] [Google Scholar]
  30. Shuman M. A. Thrombin-cellular interactions. Ann N Y Acad Sci. 1986;485:228–239. doi: 10.1111/j.1749-6632.1986.tb34585.x. [DOI] [PubMed] [Google Scholar]
  31. Smith R. A., Dupe R. J., English P. D., Green J. Acyl-enzymes as thrombolytic agents in a rabbit model of venous thrombosis. Thromb Haemost. 1982 Jun 28;47(3):269–274. [PubMed] [Google Scholar]
  32. Sundt T. M., Jr, Waltz A. G. Experimental cerebral infarction: retro-orbital, extradural approach for occluding the middle cerebral artery. Mayo Clin Proc. 1966 Mar;41(3):159–168. [PubMed] [Google Scholar]
  33. Talbot M. D., Ambler J., Butler K. D., Findlay V. S., Mitchell K. A., Peters R. F., Tweed M. F., Wallis R. B. Recombinant desulphatohirudin (CGP 39393) anticoagulant and antithrombotic properties in vivo. Thromb Haemost. 1989 Feb 28;61(1):77–80. [PubMed] [Google Scholar]
  34. Thiemermann C., May G. R., Page C. P., Vane J. R. Endothelin-1 inhibits platelet aggregation in vivo: a study with 111indium-labelled platelets. Br J Pharmacol. 1990 Feb;99(2):303–308. doi: 10.1111/j.1476-5381.1990.tb14699.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Thiemermann C., Thomas G. R., Vane J. R. Defibrotide reduces infarct size in a rabbit model of experimental myocardial ischaemia and reperfusion. Br J Pharmacol. 1989 Jun;97(2):401–408. doi: 10.1111/j.1476-5381.1989.tb11967.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Tracy P. B. Regulation of thrombin generation at cell surfaces. Semin Thromb Hemost. 1988 Jul;14(3):227–233. doi: 10.1055/s-2007-1002782. [DOI] [PubMed] [Google Scholar]
  37. Zimmerman G. A., McIntyre T. M., Mehra M., Prescott S. M. Endothelial cell-associated platelet-activating factor: a novel mechanism for signaling intercellular adhesion. J Cell Biol. 1990 Feb;110(2):529–540. doi: 10.1083/jcb.110.2.529. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES